Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRY-371797 in Third Molar Extraction Pain
NCT00663767Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of emprumapimod in odontalgia (6 arms), sponsored by Pfizer. Primary endpoints: Total Pain Relief and Safety Profile (AEs, Labs, ECG, Vitals). Started Apr 2008; status: completed.
02
Drugs
emprumapimod
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00663767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663767.